Xingang Bi

567 total citations
32 papers, 210 citations indexed

About

Xingang Bi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Xingang Bi has authored 32 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Xingang Bi's work include Renal cell carcinoma treatment (15 papers), Renal and related cancers (10 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Xingang Bi is often cited by papers focused on Renal cell carcinoma treatment (15 papers), Renal and related cancers (10 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Xingang Bi collaborates with scholars based in China and United States. Xingang Bi's co-authors include Jianzhong Shou, Jianhui Ma, Bingqing Shang, Shan Zheng, Yajian Li, Lin Feng, Lei Guo, Xi Chen, Changling Li and Zhenhua Huang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Letters.

In The Last Decade

Xingang Bi

28 papers receiving 208 citations

Peers

Xingang Bi
J.R. Jarabo Spain
Hecheng Li China
Yoko Koh Japan
Zhi‐Bo Zhang China
Tonia Kim United States
Yasuko Fuchimoto Japan
Ningning Li China
Stephanie The United States
Kate Weiss United States
J.R. Jarabo Spain
Xingang Bi
Citations per year, relative to Xingang Bi Xingang Bi (= 1×) peers J.R. Jarabo

Countries citing papers authored by Xingang Bi

Since Specialization
Citations

This map shows the geographic impact of Xingang Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingang Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingang Bi more than expected).

Fields of papers citing papers by Xingang Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingang Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingang Bi. The network helps show where Xingang Bi may publish in the future.

Co-authorship network of co-authors of Xingang Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Xingang Bi. A scholar is included among the top collaborators of Xingang Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingang Bi. Xingang Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bi, Xingang, et al.. (2025). Clinicopathological characteristics and prognosis of metastatic non-clear cell renal cell carcinoma.. Journal of Clinical Oncology. 43(5_suppl). 504–504.
2.
3.
Han, Tian, et al.. (2025). Expression and Prognostic Significance of Different Antibody-Drug Conjugate Target Proteins in Urachal Carcinoma. Clinical Genitourinary Cancer. 23(5). 102403–102403. 1 indexed citations
4.
Zhang, Qi, Yanhua Du, Dong Wang, et al.. (2025). Postoperative continuous saline bladder irrigation reduces active urinary cancer cells: a prospective study in NMIBC. Cellular Oncology. 48(4). 991–1003.
5.
6.
Bi, Xingang, Wen Zhang, Jie Wu, et al.. (2024). Neoadjuvant combined chemotherapy and immunotherapy for upper tract urothelial carcinoma: Preliminary results from a phase II study.. Journal of Clinical Oncology. 42(4_suppl). 636–636. 1 indexed citations
7.
Shang, Bingqing, et al.. (2023). Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target. Biomarker Research. 11(1). 24–24. 21 indexed citations
8.
Shang, Bingqing, Xingang Bi, Yan Song, et al.. (2023). Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma. Cancer Medicine. 12(24). 21807–21819. 5 indexed citations
9.
Wang, Ping, Yue Shi, Jianye Zhang, et al.. (2023). UCseek: ultrasensitive early detection and recurrence monitoring of urothelial carcinoma by shallow-depth genome-wide bisulfite sequencing of urinary sediment DNA. EBioMedicine. 89. 104437–104437. 7 indexed citations
10.
Shang, Bingqing, Lei Guo, Shan Zheng, et al.. (2022). Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents. Clinical & Translational Oncology. 24(7). 1333–1346. 7 indexed citations
11.
Shang, Bingqing, et al.. (2022). Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma. Journal of Oncology. 2022. 1–11. 1 indexed citations
12.
Qiu, Yuntan, Meng Meng, Jingyuan Zhang, et al.. (2021). RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma. Molecular Therapy — Nucleic Acids. 27. 241–255. 7 indexed citations
13.
Bi, Xingang, et al.. (2021). Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis. Virology Journal. 18(1). 158–158. 12 indexed citations
14.
15.
Shang, Bingqing, Liping Guo, Rongfang Shen, et al.. (2021). Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus. Frontiers in Oncology. 11. 771545–771545. 14 indexed citations
16.
Tian, Jun, Xingang Bi, Changling Li, et al.. (2020). <p>Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma</p>. Cancer Management and Research. Volume 12. 10023–10033. 4 indexed citations
17.
Chen, Xi, et al.. (2019). Targeting the deubiquitinase STAMBPL1 triggers apoptosis in prostate cancer cells by promoting XIAP degradation. Cancer Letters. 456. 49–58. 19 indexed citations
18.
Bi, Xingang, Jing Liang, Jun Tian, et al.. (2019). Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus. BMC Cancer. 19(1). 144–144. 20 indexed citations
19.
Bi, Xingang, Yaling Han, Yan Cai, et al.. (2007). [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].. PubMed. 26(2). 189–93. 1 indexed citations
20.
Chen, Xian‐Jun, Xin Xu, Jianzhong Shou, et al.. (2005). Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization. Cancer Letters. 238(2). 230–239. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.R. Jarabo Breakdown of academic impact, for papers by Hecheng Li Breakdown of academic impact, for papers by Yoko Koh Breakdown of academic impact, for papers by Zhi‐Bo Zhang Breakdown of academic impact, for papers by Tonia Kim Breakdown of academic impact, for papers by Yasuko Fuchimoto Breakdown of academic impact, for papers by Ningning Li Breakdown of academic impact, for papers by Stephanie The Breakdown of academic impact, for papers by Kate Weiss
Rankless by CCL
2026